Review—Non-Invasive Monitoring of Human Health by Exhaled Breath Analysis: A Comprehensive Review
Source abstract
Abstract
Exhaled human breath analysis is a very promising field of research work having great potential for diagnosis of diseases in non-invasive way. Breath analysis has attracted huge attention in the field of medical diagnosis and disease monitoring in the last two decades. VOCs/gases (Volatile Organic Compounds) in exhaled breath bear the finger-prints of metabolic and biophysical processes going on in human body. It’s a non-invasive, fast, non-hazardous, cost effective, and point of care process for disease state monitoring and environmental exposure assessment in human beings. Some VOCs/gases in exhaled breath are bio-markers of different diseases and their presence in excess amount is indicative of un-healthiness. Breath analysis has the potential for early detection of diseases. However, it is still underused and commercial device is yet not available owing to multiferrious challenges. This review is intended to provide an overview of major biomarkers (VOCs/gases) present in exhaled breath, importance of their analysis towards disease monitoring, analytical techniques involved, promising materials for breath analysis etc. Finally, related challenges and limitations along with future scope will be touched upon.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Chemical Sensor Technologies · Gas Sensing Nanomaterials and Sensors · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (99)
Show source-provided references
1. Current status of clinical breath analysis
2. Current status of clinicalbreath analysis10.1007/s00340-006-2280-4 ↗
3. Current status of midinfraredquantum and interband cascade lasers for clinical breathanalysis10.1117/1.3498768 ↗
4. Exhaled breath analysis for lung cancer10.3978/j.issn.2072-1439.2013.08.44 ↗
5. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography10.1073/pnas.68.10.2374 ↗
6. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study10.1016/S0140-6736(98)07552-7 ↗
7. Human exhaled breath analysis10.1016/j.anai.2011.02.016 ↗
8. Breath ammonia analysis: clinical application and measurement10.1080/10408347.2011.521729 ↗
9. Analysis of trace gases at ppb levels by proton transfer reaction mass spectrometry (PTR-MS)10.1088/0963-0252/6/2/004 ↗
10. Breath diagnostics using laser spectroscopy10.1364/OPN.16.1.000030 ↗
11. On-line monitoring of volatile organic compounds at pptvlevels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research10.1016/S0168-1176(97)00281-4 ↗
12. Proton transfer reaction mass spectrometry (PTR-MS): propanol in human breath10.1016/0168-1176(96)04369-8 ↗
13. Is breath acetone a biomarker of diabetes? A historical review on breath acetone measurements10.1088/1752-7155/7/3/037109 ↗
14. Noninvasive detection of lung cancer by analysis of exhaled breath10.1186/1471-2407-9-348 ↗
15. Human exhaled air analytics: biomarkers of diseases10.1002/bmc.835 ↗
16. Breath biomarker for clinical diagnosis and different analysis technique
17. Volatile metabolites in the exhaled breath of healthy volunteers: their levels and distributions10.1088/1752-7155/1/1/014004 ↗
18. Human exhaled air analytics: Biomarkers of diseases10.1002/bmc.835 ↗
19. Diagnostic potential of breathanalysis—focus on volatile organic compounds10.1016/j.cccn.2004.04.023 ↗
20. A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry10.1088/0967-3334/27/7/007 ↗
21. Detection of isoprene inexpired air from human subjects using proton-transfer-reaction mass spectrometry10.1002/(SICI)1097-0231(199707)11:11<1230::AID-RCM3>3.0.CO;2-Z ↗
22. Acetone, ammonia and hydrogen cyanide in exhaled breathof several volunteers aged 4–83 years10.1088/1752-7155/1/1/011001 ↗
23. Selected ion flow tube10.1002/(SICI)1097-0231(19990415)13:7<585::AID-RCM527>3.0.CO;2-K ↗
24. Increase of acetone and ammonia in urine headspace and breath during ovulation quantified using selected ion flow tube mass spectrometry10.1088/0967-3334/24/1/314 ↗
25. Breath analysis by nanostructured metal oxides as chemo-resistive gas sensors10.1016/j.mattod.2014.08.017 ↗
26. Protein turnover and amino acid catabolism
27. The urea cycle
28. Protein metabolism
29. Diagnosis of kidney failure by analysis of the concentration of ammonia in exhaled human breath
30. Hepatic encephalopathy
31. Breath ammonia measurement in Helicobacter pylori infection10.1023/A:1020568227868 ↗
32. Monitoring ammonia to assess halitosis10.1067/moe.2002.126911 ↗
33. A review of the current literature on aetiology and measurement methods of halitosis10.1016/j.jdent.2007.04.009 ↗
34. Breath condensate ammonium is lower in children with chronic asthma10.1183/09031936.05.00106204 ↗
35. The L-arginine-nitric oxide pathway10.1056/NEJM199312303292706 ↗
36. Nitric oxide as a secretory product of mammalian cells10.1096/fasebj.6.12.1381691 ↗
37. Inflammometry to assess airway diseases10.1016/S0140-6736(08)61421-X ↗
38. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections10.1183/09031936.95.08020295 ↗
39. Exhaled nitric oxide: a new lung function test10.1136/thx.51.3.233 ↗
40. Exhaled nitric oxide in chronic obstructive pulmonary disease10.1164/ajrccm.157.3.97-05009 ↗
41. Airway nitric oxide in asthmatic children and patients with cystic fibrosis10.1183/09031936.96.09122537 ↗
42. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter?10.1096/fj.02-0211hyp ↗
43. Hydrogen sulfide (H2S)–the third gas of interest for pharmacologists
44. Role of hydrogen sulfide in the realization of organism’s physiological functions
45. Hydrogen sulfide as a gasotransmitter10.1111/j.1471-4159.2010.06580.x ↗
46. Hydrogen sulfide: its production and functions10.1113/expphysiol.2011.057455 ↗
47. Role of hydrogen sulfide in secondary neuronal injury10.1016/j.neuint.2013.11.002 ↗
48. Detection of exhaled hydrogen10.1111/j.1365-2125.2010.03636.x ↗
49. Measurement of oral malodor: current methods and future prospects10.1902/jop.1992.63.9.776 ↗
50. Morning breath odor: Influence of treatments on sulfur gases10.1177/00220345000790100701 ↗
51. Clinical assessment of bad breath: current concepts10.14219/jada.archive.1996.0239 ↗
52. Nilsson
53. Acetone in breath and blood
54. Massick · 2007 · 1
55. A prototype portable breath acetone analyzer for monitoring fat loss10.1088/1752-7155/7/3/036005 ↗
56. A novel MVA-mediated pathway for isoprene production in engineered E. coli10.1186/s12896-016-0236-2 ↗
57. Breath isoprene in patients with heart failure10.1016/S1388-9842(01)00128-3 ↗
58. Ethane evolution: a new index of lipid peroxidation10.1126/science.183.4121.208 ↗
59. Random forests10.1023/A:1010933404324 ↗
60. Bootstrap methods: another look at the jackknife10.1214/aos/1176344552 ↗
61. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array10.1136/thx.2006.072892 ↗
62. Shawe-Taylor · 2004
63. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease10.1164/ajrccm.162.2.9909025 ↗
64. Methods for measuring ethane and pentane in expired air from rats and humans10.1016/S0891-5849(99)00230-0 ↗
65. Lipid peroxidation and plasma antioxidant micronutrients in Crohn’s disease10.1093/ajcn/74.2.259 ↗
66. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea10.1378/chest.111.6.1500 ↗
67. Diet and oxidative stress in breast, colon and prostate cancer patients: A case-control study
68. Breath pentane and plasma lipid peroxides in ischemic heart disease10.1016/0891-5849(95)00053-Z ↗
69. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health10.1080/10408440591002183 ↗
70. Neuroprotection incerebral ischemia by neutralization of 3-aminopropanal10.1073/pnas.082609299 ↗
71. 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin10.1042/bj20021520 ↗
72. Major differences exist in the function and tissue-specific expressionof human aflatoxin B1 aldehyde reductase and the principal humanaldo-keto reductase AKR1 family members10.1042/0264-6021:3430487 ↗
73. Selective vulnerability of spinal motor neurons toreactivedicarbonyl compounds, intermediate products of glycation,in vitro: Implication of inefficient glutathione system in spinal motorneurons10.1016/S0006-8993(00)02047-3 ↗
74. Pavia · 2006 · 797
75. GC analysis of human breath with a series-coupled column ensemble and a multibed sorption trap10.1021/ac020725g ↗
76. Breath analysis and monitoring by membrane extraction with sorbent interface10.1021/ac025863k ↗
77. Application of low-temperature glassy carbon-coated macrofibers for solid-phase microextraction analysis of simulated breath volatiles10.1021/ac025984k ↗
78. Method for the collection and analysis of volatile compounds in the breath10.1016/0378-4347(91)80086-R ↗
79. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study10.18632/oncotarget.21335 ↗
80. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia10.1038/srep17179 ↗
81. Exhaled human breath analysis in active pulmonary tuberculosis diagnostics by comprehensive gas chromatography-mass spectrometry and chemometric techniques10.1088/1752-7163/aae80e ↗
82. Exhaled breath analysis for gastric cancer diagnosis in Colombian patients10.18632/oncotarget.25331 ↗
83. Proton transfer reaction mass spectrometry: on-line trace gas analysis at ppb level10.1016/0168-1176(95)04294-U ↗
84. Applications of breath gas analysis in medicine10.1016/j.ijms.2004.08.010 ↗
85. Human breath isoprene and its relation to bloodcholesterol levels: new measurements and modeling10.1152/jappl.2001.91.2.762 ↗
86. Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors10.1002/hed.20779 ↗
87. PTR-MS real time monitoring of the emission of volatile organic compounds during postharvest aging of berry fruit10.1016/S0925-5214(99)00052-6 ↗
88. The selected ion flow tube (SIFT); A technique for studying ion-neutral reactions10.1016/0020-7381(76)80133-7 ↗
89. Quantification of breath isoprene using the selected ion flow tube mass spectrometric analytical method10.1002/(SICI)1097-0231(19990915)13:17<1733::AID-RCM707>3.0.CO;2-S ↗
90. Time variation of ammonia, acetone, isoprene and ethanol in breath: A quantitative SIFT-MS study over 30 days10.1088/0967-3334/24/1/308 ↗
91. Quantification of acetonitrile in exhaled breath and urinary headspace using selected ion flow tube mass spectrometry10.1016/S1387-3806(03)00212-4 ↗
92. Helicobacter pylori infection frompathogenesis to treatment: a critical reappraisal10.1046/j.1365-2036.16.s4.20.x ↗
93. The novel selected ion flow tube approach trace gas analysis of air and breath10.1002/(SICI)1097-0231(19960731)10:10<1183::AID-RCM641>3.0.CO;2-3 ↗
94. Single exhaled breath metabolomic analysis identifies unique breathprintin patients with acute decompensated heart failure10.1016/j.jacc.2012.12.033 ↗
95. Cardiovascular biomarkers in exhaled breath10.1016/j.pcad.2012.05.005 ↗
96. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children10.1097/MEG.0b013e3283650669 ↗
97. The breath prints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis10.1016/j.cgh.2013.08.048 ↗
98. The use of a portable breath analysis device in monitoring type 1 diabetes patients in a hypoglycaemic clamp: validation with sift-ms data10.1088/1752-7155/8/3/037108 ↗
99. Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes10.1088/1752-7155/5/4/046011 ↗